microRNA-22 Inhibition Stimulates Mitochondrial Homeostasis and Intracellular Degradation Pathways to Prevent Muscle Wasting
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26209900 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Simone Tomasini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for RNA Medicine, Department of Clinical Medicine, Aalborg University, 2450 Copenhagen, Denmark. Hauptthemen laut MEDLINE: MicroRNAs, Muscular Atrophy, Homeostasis, Mitochondria. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, Fondazione Umberto Veronesi.
Abstract (Originalsprache)
MicroRNA-22 (miR-22) is a negative regulator of mitochondrial biogenesis, as well as lipid and glucose metabolism, in metabolically active tissues. Silencing miR-22 holds promise as a potential treatment of obesity and metabolic syndrome, as it restores metabolic capacity—enhancing oxidative metabolism—and reduces ectopic fat accumulation in chronic obesity, a driver of impaired metabolic flexibility and muscle mass loss. Intramuscular adipose accumulation and defective mitochondrial function are features associated with obese-mediated muscle atrophy and hallmarks of neuromuscular disorders such as Duchenne muscular dystrophy. Therefore, miR-22 could represent a compelling molecular target to improve muscle health across various muscle-wasting conditions. This study describes a pharmacological strategy for the inhibition of miR-22 in skeletal muscle by employing a mixmer antisense oligonucleotide (ASO, anti-miR-22). Administration of the ASO in a mouse model of obesity positively modulated myogenesis while protecting dystrophic mice from muscle function decline, enhancing fatigue resistance, and limiting pathological fibrotic remodeling. Mechanistically, we show that anti-miR-22 treatment promotes derepression of genes involved in mitochondrial homeostasis, favoring oxidative fiber content regardless of the disease model, thus promoting a more resilient phenotype. Furthermore, we suggest that miR-22 inhibition increases autophagy by transcriptional activation of multiple negative regulators of mammalian target of rapamycin (mTOR) signaling to decrease immune infiltration and fibrosis. These findings position miR-22 as a promising therapeutic target for muscle atrophy and support its potential to restore muscle health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for RNA Medicine, Department of Clinical Medicine, Aalborg University, 2450 Copenhagen, Denmark.
- Department of Life Sciences and Systems Biology, University of Turin, 10124 Torino, Italy.
- Resalis Therapeutics Srl, Via E. De Sonnaz 19, 10121 Torino, Italy.
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Pharmacology and Toxicology Section, University of Florence, Viale G. Pieraccini 6, 50139 Firenze, Italy.
- Department of Health Science and Technology, Aalborg University, 9220 Aalborg, Denmark.
- RNA Therapeutics, Translational Research Centre, Rigshospitalet, 2600 Glostrup, Denmark.
ORCID-Profile: Simone Tomasini, Emanuele Monteleone, Francesco Margiotta, Hiva Alipour, Anja Holm
Förderung
- Novo Nordisk Foundation
- Fondazione Umberto Veronesi
Zitieren
APA
Tomasini, S., Monteleone, E., Altieri, A., Margiotta, F., Dardmeh, F., Alipour, H., Holm, A., Kauppinen, S., & Panella, R. (2025). microRNA-22 Inhibition Stimulates Mitochondrial Homeostasis and Intracellular Degradation Pathways to Prevent Muscle Wasting. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26209900
Vancouver
Tomasini S, Monteleone E, Altieri A, Margiotta F, Dardmeh F, Alipour H, et al. microRNA-22 Inhibition Stimulates Mitochondrial Homeostasis and Intracellular Degradation Pathways to Prevent Muscle Wasting. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26209900
BibTeX
@article{Tomasini2025,
author = {Tomasini, Simone and Monteleone, Emanuele and Altieri, Anna and Margiotta, Francesco and Dardmeh, Fereshteh and Alipour, Hiva and Holm, Anja and Kauppinen, Sakari and Panella, Riccardo},
title = {microRNA-22 Inhibition Stimulates Mitochondrial Homeostasis and Intracellular Degradation Pathways to Prevent Muscle Wasting},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26209900}
}
EUVIMED